Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2025 16:23 ET | Source: Serina Therapeutics, Inc.

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

On track for first patient dosing of SER-252 in Phase 1b clinical trial in advanced Parkinson’s disease in Q4 2025Strengthened balance sheet with recent financingAdvancing innovative POZ Platform...
April 29, 2025 06:00 ET | Source: Serina Therapeutics, Inc.

Serina Therapeutics to Present at JonesResearch Virtual CNS Day

HUNTSVILLE, AL, April 29, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug...